25 companies had executives and directors buying on the open market in filings dated Feb 11, 2026, about $255.3 million combined. The biggest was SGP (SpyGlass Pharma, Inc.), where RA Capital Healthcare Fund LP led about $216.2 million of buying.
Four of the buys came from a CEO or CFO. 49 companies had three or more insiders buying in the past 30 days. Each filing is linked below if you want to check the details yourself.